Veraxa Biotech Holding AG (VRXA) Long-Term Deferred Tax (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Long-Term Deferred Tax came in at $2.1 million in Q4 2025, up 28.57% year-on-year from $1.6 million in Q4 2024, and up 28.57% on a QoQ basis from $1.6 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Long-Term Deferred Tax data on file, last reported at $2.1 million in Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax rose 28.57% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 28.57% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 28.57% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $2.1 million, up from $1.6 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for VRXA reached as high as $2.1 million in Q4 2025 and fell as low as $1.6 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | 1.60 Mn |